Clinical trial
Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain
NCT01615627 is registered in ClinicalTrials.gov with Jewish General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain
- Lead sponsor
- Jewish General Hospital
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- July 1, 2012
- Completion date
- February 28, 2019
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.